LMAT 241018 90.00C (LMAT241018C90000) Stock Options, News & Quotes

US OptionsDetailed Quotes

LMAT241018C90000

Watchlist

3.75
-0.50-11.76%

15min DelayClose Sep 27 16:00 ET

3.75High3.75Low

Intraday

5D
Daily

News

LeMaitre Vascular Is Maintained at Outperform by Barrington Research
Dow JonesSep 20 11:31 ET · Ratings
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $92
Moomoo NewsSep 20 10:31 ET · Ratings
Lemaitre Vascular's Growth Prospects Bolstered by Pricing Power and Strategic Expansion: A Buy Rating Review
TipRanksSep 20 10:20 ET · Ratings
Possible Bearish Signals With LeMaitre Vascular Insiders Disposing Stock
Simply Wall StSep 17 10:15 ET
Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Yahoo FinanceSep 15 09:15 ET
LeMaitre Vascular (NASDAQ:LMAT) Shareholders Have Earned a 25% CAGR Over the Last Five Years
Yahoo FinanceAug 31 10:17 ET

Comments

Moomoo AI

Feb 9 06:29

The significant insider selling of LeMaitre Vascular shares, especially by the Chairman & CEO, and the absence of insider purchases, may worry shareholders. Yet, the high insider ownership could suggest the company operates in all shareholders' interest.

LeMaitre Vascular Insiders Sell US$5.3m Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 27, 2023 06:06

High level of insider ownership suggests long-term benefit for company. Recent substantial insider selling at a higher price than current stock value might concern shareholders.

LeMaitre Vascular Insiders Sold US$1.3m Of Shares Suggesting Hesitancy

Moomoo AI

Oct 11, 2023 08:07

LeMaitre Vascular's short-term returns show decline but its growth reinvestment and increasing sales are encouraging. With a continuation in growth trends and a past record of 112% return over five years, the stock appears promising for long-term investors.

Capital Allocation Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Ideal